Literature DB >> 23535719

Spatial learning impairments in PLB1Triple knock-in Alzheimer mice are task-specific and age-dependent.

D Ryan1, D Koss, E Porcu, H Woodcock, L Robinson, B Platt, G Riedel.   

Abstract

We recently generated an advanced mouse model of Alzheimer's disease (AD) by targeted knock-in of single-copy mutated human amyloid precursor-protein (APP) and tau genes, crossed with a non-symptomatic presenilin (PS1A246E) over-expressing mouse line. These PLB1Triple mice presented with age-dependent and AD-relevant phenotypes. Homozygous PLB1Triple mice aged 4-12 months were assessed here in a battery of spatial learning tasks: Exp.1 radial-arm water maze (spatial reference and working memory) Exp.2 open-field water maze (spatial reference memory); Exp.3 home cage observation system with spatial learning (IntelliCage); Exp.4 spontaneous object recognition (SOR; novel object and spatial object shift). A separate test with high-expression transgenic APP mice matching the design of experiment 1 was also performed. Spatial deficits in PLB1Triple mice were confirmed at 12, but not 4 months in both water maze tasks. PSAPP mice, by contrast, presented with severe yet non-progressive spatial learning deficits already at 4 months. During tests of spatial learning in SOR and IntelliCage, PLB1Triple mice neither acquired the location of the water-rewarded corner, nor recognize novel or spatially shifted objects at 4 months, indicating these protocols to be more sensitive than the water maze. Collectively and in line with AD symptomatology, PLB1Triple mice present with a graded and progressive age-dependent loss of spatial memory that can be revealed by the use of a battery of tasks. With the emergence of subtle deficits progressively increasing in severity, PLB1Triple mice may offer a more patho-physiologically relevant model of dementia than aggressive expression models.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23535719     DOI: 10.1007/s00018-013-1314-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  72 in total

Review 1.  Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease.

Authors:  D T Kobayashi; K S Chen
Journal:  Genes Brain Behav       Date:  2005-04       Impact factor: 3.449

2.  A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data.

Authors:  A Ennaceur; J Delacour
Journal:  Behav Brain Res       Date:  1988-11-01       Impact factor: 3.332

3.  Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.

Authors:  Karin Boekhoorn; Dick Terwel; Barbara Biemans; Peter Borghgraef; Olof Wiegert; Ger J A Ramakers; Koos de Vos; Harm Krugers; Takami Tomiyama; Hiroshi Mori; Marian Joels; Fred van Leuven; Paul J Lucassen
Journal:  J Neurosci       Date:  2006-03-29       Impact factor: 6.167

4.  Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

Authors:  J Lewis; D W Dickson; W L Lin; L Chisholm; A Corral; G Jones; S H Yen; N Sahara; L Skipper; D Yager; C Eckman; J Hardy; M Hutton; E McGowan
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

5.  Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.

Authors:  Lauren M Billings; Salvatore Oddo; Kim N Green; James L McGaugh; Frank M LaFerla
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

6.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

7.  Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology.

Authors:  Manuela Polydoro; Christopher M Acker; Karen Duff; Pablo E Castillo; Peter Davies
Journal:  J Neurosci       Date:  2009-08-26       Impact factor: 6.167

8.  Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice.

Authors:  Virginie Rhein; Xiaomin Song; Andreas Wiesner; Lars M Ittner; Ginette Baysang; Fides Meier; Laurence Ozmen; Horst Bluethmann; Stefan Dröse; Ulrich Brandt; Egemen Savaskan; Christian Czech; Jürgen Götz; Anne Eckert
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-06       Impact factor: 11.205

9.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.

Authors:  D Games; D Adams; R Alessandrini; R Barbour; P Berthelette; C Blackwell; T Carr; J Clemens; T Donaldson; F Gillespie
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

10.  Impaired "episodic-like" object memory in adult APPswe transgenic mice.

Authors:  Mark A Good; Gemma Hale; Victoria Staal
Journal:  Behav Neurosci       Date:  2007-04       Impact factor: 1.912

View more
  12 in total

1.  Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model.

Authors:  Cheng Zhang; Ching-Chang Kuo; Setareh H Moghadam; Louise Monte; Kenner C Rice; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits.

Authors:  Dave J Koss; Lianne Robinson; Anna Mietelska-Porowska; Anna Gasiorowska; Kristina Sepčić; Tom Turk; Marcel Jaspars; Grazyna Niewiadomska; Roderick H Scott; Bettina Platt; Gernot Riedel
Journal:  Cell Mol Life Sci       Date:  2015-06-13       Impact factor: 9.261

Review 3.  Update of neurotrophic factors in neurobiology of addiction and future directions.

Authors:  Maryna Koskela; Susanne Bäck; Vootele Võikar; Christopher T Richie; Andrii Domanskyi; Brandon K Harvey; Mikko Airavaara
Journal:  Neurobiol Dis       Date:  2016-05-14       Impact factor: 5.996

4.  Age-dependent changes in hippocampal synaptic transmission and plasticity in the PLB1Triple Alzheimer mouse.

Authors:  David J Koss; Benjamin D Drever; Sandra Stoppelkamp; Gernot Riedel; Bettina Platt
Journal:  Cell Mol Life Sci       Date:  2013-02-14       Impact factor: 9.261

5.  Knock-in of human BACE1 cleaves murine APP and reiterates Alzheimer-like phenotypes.

Authors:  Kaja Plucińska; Barry Crouch; David Koss; Lianne Robinson; Michael Siebrecht; Gernot Riedel; Bettina Platt
Journal:  J Neurosci       Date:  2014-08-06       Impact factor: 6.167

6.  Effect of Scopolamine on Mice Motor Activity, Lick Behavior and Reversal Learning in the IntelliCage.

Authors:  Péter Pelsőczi; György Lévay
Journal:  Neurochem Res       Date:  2017-10-11       Impact factor: 3.996

7.  Gene therapy using Aβ variants for amyloid reduction.

Authors:  Kyung-Won Park; Caleb A Wood; Jun Li; Bethany C Taylor; SaeWoong Oh; Nicolas L Young; Joanna L Jankowsky
Journal:  Mol Ther       Date:  2021-02-27       Impact factor: 12.910

8.  Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer's disease and frontotemporal lobar degeneration.

Authors:  V Melis; C Zabke; K Stamer; M Magbagbeolu; K Schwab; P Marschall; R W Veh; S Bachmann; S Deiana; P-H Moreau; K Davidson; K A Harrington; J E Rickard; D Horsley; R Garman; M Mazurkiewicz; G Niewiadomska; C M Wischik; C R Harrington; G Riedel; F Theuring
Journal:  Cell Mol Life Sci       Date:  2014-12-19       Impact factor: 9.261

9.  Sex differences in the IntelliCage and the Morris water maze in the APP/PS1 mouse model of amyloidosis.

Authors:  Marc A Mifflin; Wendy Winslow; Likith Surendra; Savannah Tallino; Austin Vural; Ramon Velazquez
Journal:  Neurobiol Aging       Date:  2021-01-23       Impact factor: 4.673

10.  NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication.

Authors:  Rafal T Olszewski; Karolina J Janczura; Tomasz Bzdega; Elise K Der; Faustino Venzor; Brennen O'Rourke; Timothy J Hark; Kirsten E Craddock; Shankar Balasubramanian; Charbel Moussa; Joseph H Neale
Journal:  Neurochem Res       Date:  2017-03-11       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.